Protocol Name: CV Outcomes Study with CSL300 (Clazakizumab) in Adults with ESKD Undergoing Dialysis (POSIBIL6ESKD)
Protocol #: CSL300_2301 (POSIBIL6ESKD)
Indication: Dialysis
GFR: n/a
Principal Investigator: Bernard Fischbach, MD, CCRP
Location: Landry Center, 411 N. Washington Ave, Suite #6000, Dallas, TX 75246